[1]
“DAPAGLIFLOZIN: NEWER MOLECULE FOR TREATMENT OF TYPE 2 DIABETES MELLITUS”, Int. Res. J. Pharm., vol. 9, no. 11, pp. 76–84, Nov. 2018, Accessed: Jul. 29, 2026. [Online]. Available: https://irjponline.org/index.php/irjp/article/view/1915